See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2014_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 80,515,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,478,000 |
| 3 | remainder_Assets | 7,730,000 |
| 4 | LiabilitiesCurrent | 20,069,000 |
| 5 | LiabilitiesNoncurrent | 15,809,000 |
| 6 | remainder_Liabilities | 1,626,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 42,288,000 |
| 9 | ResearchAndDevelopmentExpense | 33,624,000 |
| 10 | remainder_Expenses | 292,000 |
| 11 | remainder_Revenues | 34,678,000 |
| 12 | remainder_NetIncome | -2,024,000 |
| 13 | remainder_ComprehensiveNetIncome | 651,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,723,000 |
| 1 | Liabilities | 37,504,000 |
| 2 | Expenses | 76,204,000 |
| 3 | Revenues | 34,678,000 |
| 4 | StockholdersEquity | 56,219,000 |
| 5 | NetIncome | -43,550,000 |
| 6 | ComprehensiveNetIncome | -43,224,500 |
| 7 | BaseVar | 122,392,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.21 |
| 9 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
